$0.96
+0.04 (+4.19%)
BJDX News4 articles
Bluejay Diagnostics Stock Jumps 47% Premarket Despite Warrant Hurdles
Bluejay Diagnostics (BJDX) shares soared 47% premarket, but the rally leaves the stock below the warrant strike price, complicating financing plans.
Bluejay Diagnostics Surge Snags on June Warrants Hurdle
Bluejay Diagnostics stock rallied 26.7% in pre-market on July 7, 2026, but remains below June warrant exercise prices and private placement levels.
Bluejay Diagnostics Surges on US Manufacturing Pact, but Funding Concerns Loom
Bluejay Diagnostics (BJDX) jumped up to 213% in premarket after a US manufacturing deal with Argonaut, but the stock is volatile as Symphony awaits FDA clearance and funding is needed.
Bluejay Diagnostics Stock Surges 171% on U.S. Manufacturing Deal, FDA Hurdle Remains
Bluejay Diagnostics shares surged 171% to $5.88 after announcing a U.S. manufacturing partnership for its Symphony sepsis-testing platform, but the stock faces risks from pending FDA clearance and ongoing capital needs.